| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |